Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24183355 | 1.00 | KDM4E (0.42) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL16574231 | 0.91 | KDM4E (0.44) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL24086890 | 0.90 | KDM4E (0.39) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL16569816 | 0.89 | KDM4E (0.42) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL19380719 | 0.89 | KDM4E (0.42) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL13346535 | 0.88 | KDM4E (0.38) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL15105564 | 0.86 | KDM4E (0.37) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1012047 | 0.84 | KDM4E (0.48) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL23619098 | 0.83 | ALDH1A1 (0.39) | KDM4EALDH1A1TDP1 | |
| SCHEMBL4787657 | 0.83 | KDM4E (0.43) | KDM4EALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109313388-B | Negative photosensitive composition | 住友电木株式会社 | 2022-06-21 | — | — | CN | claimed |
| US-10712661-B2 | Negative tone photosensitive compositions | PROMERUS, LLC (US) | 2020-07-14 | — | — | US | claimed |
| US-20170357156-A1 | NEGATIVE TONE PHOTOSENSITIVE COMPOSITIONS | PROMERUS, LLC (US) | 2017-12-14 | — | — | US | claimed |
| EP-4744462-A1 | COMPOSITION | Merck Patent GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4605438-A1 | COMPOSITION | Merck Patent GmbH (DE) | 2025-08-27 | — | — | EP | disclosed |
| EP-3565850-B1 | POLYCYCLOOLEFIN POLYMER COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS LLC (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120077076-A | Composition and method for producing the same | 默克专利有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20250122402-A1 | LONG SHELF-LIFE STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS CONTAINING PYRIDINE LIGATED PALLADIUM COMPOUNDS | PROMERUS, LLC (US) | 2025-04-17 | — | — | US | disclosed |
| WO-2025012183-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2025-01-16 | — | — | WO | disclosed |
| CN-116096760-B | Hindered amine stabilized UV-active organopalladium catalyzed polycycloolefin compositions as optical materials | 住友电木株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-118317992-A | Dual UV blocker comprising a shelf-life stable photoactive bulk polymerized polycycloolefin composition as an optical material | 普罗米鲁斯有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2017117483-A1 | POLYMERS DERIVED FROM NORBORNADIENE AND MALEIC ANHYDRIDE AND USE THEREOF | PROMERUS, LLC (US) | 2017-07-06 | — | — | WO | disclosed |
| US-20170190810-A1 | POLYMERS DERIVED FROM NORBORNADIENE AND MALEIC ANHYDRIDE AND USE THEREOF | PROMERUS, LLC (US) | 2017-07-06 | — | — | US | disclosed |
| US-20170190810-A1 | POLYMERS DERIVED FROM NORBORNADIENE AND MALEIC ANHYDRIDE AND USE THEREOF | PROMERUS, LLC (US) | 2017-07-06 | — | — | US | disclosed |
| US-9261781-B2 | Preparation of norbornane-based PAC ballasts | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20130323640-A1 | Preparation of Norbornane-based PAC Ballasts | SUMITOMO BAKELITE CO., LTD. (JP) | 2013-12-05 | — | — | US | disclosed |
| US-8530133-B2 | Preparation of norbornane-based PAC ballasts | PROMERUS, LLC (US) | 2013-09-10 | — | — | US | disclosed |
| EP-2622410-A1 | NORBORNANE-BASED PAC BALLAST AND POSITIVE-TONE PHOTOSENSITIVE RESIN COMPOSITION ENCOMPASSING THE PAC | Promerus, LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20120135352-A1 | Preparation of Norbornane-based PAC Ballasts | PROMERUS LLC (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2012044719-A1 | NORBORNANE-BASED PAC BALLAST AND POSITIVE-TONE PHOTOSENSITIVE RESIN COMPOSITION ENCOMPASSING THE PAC | PROMERUS LLC (US) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135352-A1 | Preparation of Norbornane-based PAC Ballasts | NBAS, PHB2, BDNF | KDM4E 3783/4885ALDH1A1 2492/4885TSHR 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.